基本信息
- 标准SMILES
[Mg+2].[OH-].[OH-]- InChIKey
VTHJTEIRLNZDEV-UHFFFAOYSA-L- 分子式
- H2MgO2
- 平均分子量
- 58.32 g/mol
概述
Magnesium dihydroxide is a magnesium hydroxide in which the magnesium atom is bound to two hydroxide groups. It has a role as an antacid and a flame retardant.
名称与标识
- 首选名称
- Magnesium Hydroxide
- IUPAC
- magnesium dihydroxide
- 中文名
- 氢氧化镁
- 英文名
- Magnesium hydroxide
- 分子式
- H2MgO2
- 分子量
- 58.32
名称与别名
展开更多名称
数据库标识
- CAS
1309-42-8、1317-43-7- PubChem CID
- 73981
- DTXSID
DTXSID4049662- ChEMBL
CHEMBL1200718- ChEBI
CHEBI:6637- UNII
- NBZ3QY004S
- EC Number
- 215-170-3
- Nikkaji
- J43.883I
性质
结构计算性质
- 极性表面积
- 2 Ų
- 氢键供体
- 2
- 氢键受体
- 2
- 可旋转键
- 0
- 重原子
- 3
- 形式电荷
- 0
- 复杂度
- 0
实验与物化性质
Polymers
Plastics -> Flame retardants
Plastics -> Polyolefin-I; Polyolefin-II; ABS
Cosmetics
Cosmetic ingredients (Magnesium Hydroxide) -> CIR (Cosmetic Ingredient Review)
Buffering; Absorbent
Pesticides
Agrochemicals -> Pesticide active substances
Active substance -> EU Pesticides database: Approved
Density
2.36 g/mL
2.36 @25 °C
Color/Form
Amorphous powder
White, hexagonal crystals
Granules
Solubility
Practically insoluble in water and in ethanol
White, friable masses or bulky, white powder; at about 700 °C is converted to MgO; sol in about 3,300 parts CO2-free water; more sol in water containing CO2; sol in dilute acids with effervescence; insol in alcohol /Magnesium carbonate hydroxide/
Soluble in dilute acids
0.0009 G SOL IN 100 CC WATER @ 18 °C; 0.004 G SOL IN 100 CC WATER @ 100 °C; SOL IN AMMONIUM SALTS
Almost insoluble in alcohol
物理化学性质
- 熔点
- 350 °C · 350 °C (lit.)
- 密度
- 2 · 2,36 g/cm3
- 储存条件
- Room Temperature
- 溶解度
- 5 M · 5 M HCl: 0.1 M, clear, yellow
- 形态
- powder
- 颜色
- White
- 比重
- 2.36 · 2.36
- 气味 (Odor)
- Odorless
- PH值
- 10.4 · 10.4(1 mM solution);10.4(10 mM solution);10.4(100 mM solution)
- 酸碱指示剂变色ph值范围
- 9.5 · 9.5 - 10.5
- 水溶解性
- 0.9 mg/100 · 0.9 mg/100 mL (18 ºC)
- 比热容
- 1.32 J/ · Cp(crystal): 1.32 J/(g·K), at 25℃
- 最大波长(λmax)
- 260 nm · λ: 260 nm Amax: 0.030λ: 280 nm Amax: 0.025
- 敏感性
- Air Sensitive
- Merck
- 14 · 14,5670
- Ksp沉淀平衡常数
- 11.25 · pKsp: 11.25
- 稳定性
- Stable.
- 化妆品成分功效
- ABSORBENTBUFFERING
- 化妆品成分评估
- Magnesium hydroxide (1309-42-8)
- InChI
- 1S/Mg.2H2O/h;2*1H2/q+2;;/p-2
- InChIKey
- VTHJTEIRLNZDEV-UHFFFAOYSA-L
- SMILES
- O[Mg]O
- LogP
- -1.38 · -1.380 (est)
- CAS 数据库
- 1309 · 1309-42-8(CAS DataBase Reference)
- NIST化学物质信息
- Magnesium hydroxide(1309-42-8)
- EPA化学物质信息
- 2 · Magnesium hydroxide (Mg(OH)2) (1309-42-8)
化学性质
氢氧化镁是一种常见的镁盐化合物,化学式Mg(OH)2。分子量58.33。白色六方晶体或无定形粉末。 相对密度2.36。350℃ 时失去1分子水,生成MgO。溶于稀酸和铵盐溶液,几乎不溶于水和醇。在水中溶解度(18℃)为0.0009g/100g。当有水存在时吸收二氧化碳生成碱式碳酸镁或碳酸镁。在自然界以水镁石矿形式存在。氢氧化镁的乳状悬浮液在医药上用做抗酸剂和缓泻剂,由镁盐 (如氯化镁或硫酸镁) 与氢氧化钠溶液反应而制得;用海水和廉价的石灰乳反应,也可得到氢氧化镁沉淀 (氧化镁乳):Mg2++Ca(OH)2=Mg(OH)2+Ca2+
安全与法规
GHS分类
GHS Classification
Not Classified
Aggregated GHS information provided per 736 reports by companies from 13 notifications to the ECHA C&L Inventory.
危害信息
Regulatory Information
Chemical: Magnesium hydroxide (Mg(OH)2)
Magnesium hydroxide (Mg(OH)2) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Magnesium hydroxide (Mg(OH)2) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Reg. (EU) 2024/836
Status: Active Update: 21-04-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/16073
Magnesium hydroxide: Does not have an individual approval but may be used under an appropriate group standard
FDA Requirements
This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Substance added directly to human food affirmed as generally recognized as safe (GRAS).
Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. Magnesium hydroxide is included in digestive aid products.
The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed over-the-counter drug products, incl magnesium hydroxide, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.
Antacid products for over-the-counter (OTC) human use. Magnesium hydroxide is included on this list of specific active ingredients.
Hazardous Reactivities and Incompatibilities
Phosphorus boiled with alkaline hydroxides yields mixed phosphines which may ignite spontaneously in air. /Alkaline hydroxides/
ALKALI & OTHER ALKALINE EARTH COMPD...MAGNESIUM COMPD...CAUSE EXPLOSIVE DECOMP OF MALEIC ANHYDRIDE.
安全与防护
Disposal Methods
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Protective Action Criteria (PAC)
26 [mg/m3]
280 [mg/m3]
1700 [mg/m3]
毒理信息
Interactions
...MAGNESIUM HYDROXIDE MAY INTERFERE WITH ABSORPTION OF WARFARIN BY ALKALINIZING GASTROINTESTINAL CONTENTS. ...IT HAS BEEN DEMONSTRATED THAT MAGNESIUM HYDROXIDE SUSPENSION ACTUALLY ENHANCES THE ABSORPTION OF DICUMAROL...HIGHER PEAK SERUM LEVELS...
ALKALINIZATION OF URINE CAN DECR EXCRETION OF VARIOUS WEAKLY BASIC DRUGS (EG QUINIDINE). MG(OH2) INCR ABSORPTION OF WARFARIN IN MAN & DECR ABSORPTION OF BARBITURATES IN RATS.
Toxicity Summary
The CIR Expert Panel concluded that ... Magnesium Hydroxide is safe in hair straighteners and depilatories under conditions of recommended use; users should minimize skin contact. These ingredients are safe for all other present practices of use and concentration described in this safety assessment when formulated to be nonirritating.
Safe for use in cosmetics, with qualifications
Natural Pollution Sources
OCCURS IN NATURE AS THE MINERAL BRUCITE.
OCCURS AS AN ALTERATION PRODUCT OF PERICLASE IN SERPENTINE AND MARBLE AND IN CHLORITE AND DOLOMITE SCHISTS
Human Toxicity Excerpts
/HUMAN EXPOSURE STUDIES/ Compounds with a basic pH are potentially even more damaging to the eye than are strong acids. Among the compounds of clinical significance in terms of frequency and severity of injuries are ... magnesium hydroxide.
/HUMAN EXPOSURE STUDIES/ IF EVACUATION FAILS (BOWEL OBSTRUCTION OR ATONY), MUCOSAL IRRITATION & ABSORPTION OCCUR. SYSTEMICALLY MG PRODUCES CNS DEPRESSION, ABOLITION OF REFLEXES, & DEATH FROM RESP PARALYSIS.
/HUMAN EXPOSURE STUDIES/ PROLONGED USE OF MG(OH)2 MAY RARELY CAUSE RECTAL STONES COMPOSED OF MGCO3 & MG(OH)2.
Non-Human Toxicity Excerpts
/LABORATORY ANIMALS: Acute Exposure/ ...IN DOGS, THE MAGNESIUM CONTENT OF GASTRIC MUCOSA & MUSCULARIS IS INCR & IT IS POSSIBLE THAT THE EFFECT TO DECR ANTRAL MOTILITY & UROPEPSIN SECRETION IS FROM A DIRECT LOCAL ACTION.
/LABORATORY ANIMALS: Acute Exposure/ ...MILK OF MAGNESIA ON RABBIT EYES...TWICE A DAY FOR THREE OF FOUR DAYS CAUSED DAMAGE TO CORNEAL EPITHELIUM DEMONSTRABLE BY STAINING WITH FLUORESCEIN. AFTER THE APPLICATIONS...WERE DISCONTINUED, CORNEAS RETURNED TO NORMAL IN TWO OR THREE DAYS.
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ The effects of magnesium hydroxide were examined on methylazoxymethanol (MAM) acetate-induced c-myc expression and cell proliferation of colonic mucosal epithelium in rats. Rats were divided into four groups and treated as follows: MAM acetate alone (25 mg/kg i.p. injection, five times, once a week for 5 weeks), MAM acetate and feeding of 0.2% magnesium hydroxide in diet, magnesium hydroxide alone and non-treatment. At 4, 8 and 16 weeks after the start of experiment, 10 rats in each group were sacrificed. Magnesium hydroxide inhibited the MAM-induced expression of c-myc proto-oncogene, and also suppressed the increased bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) labelling indexes induced by MAM acetate in colon mucosa in initiation and post-initiation phase. These results suggest that the anti-carcinogenic effect of magnesium hydroxide on rat colon carcinogenesis induced by MAM acetate may be related to the inhibition of the carcinogen-induced expression of c-myc proto-oncogene and cell proliferation.
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Preventive effect of magnesium hydroxide on carcinogen-induced, large bowel carcinogenesis was examined in three experiments using F344 rats. Experiment I: Rats received dietary administration of magnesium hydroxide at concentrations of 500 or 1,000 ppm after treatment with methylazoxymethanol (MAM) acetate (25 mg/kg, 3 times). These rats had a lower incidence of large bowel neoplasms than animals given MAM acetate alone. Reduction of the tumor incidence was especially significant at a dose of 500 ppm. Experiment II: Rats given magnesium hydroxide (250, 500, or 1,000 ppm) together with 1,2-dimethylhydrazine (DMH) (20 mg/kg, 10 times) showed a lower multiplicity of large bowel tumors than those given DMH alone. Experiment III: The labeling indices of the cryptal cells of the large bowel (cecum or proximal colon or distal colon) or rates given magnesium hydroxide for 4, 6, or 8 weeks after treatment with MAM acetate (25 mg/kg, 3 times) were smaller than those of animals given MAM acetate alone, indicating that magnesium hydroxide suppressed, carcinogen-induced epithelial cell (large bowel) proliferation. The results of the three experiments suggest that magnesium, one of the essential metals, is a promising chemopreventive agent in humans.
Non-Human Toxicity Values
LD50 Rat oral 8500 mg/kg
LD50 Rat intraperitoneal 2780 mg/kg
法规信息
FDA Requirements
This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Substance added directly to human food affirmed as generally recognized as safe (GRAS).
Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. Magnesium hydroxide is included in digestive aid products.
The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed over-the-counter drug products, incl magnesium hydroxide, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.
Antacid products for over-the-counter (OTC) human use. Magnesium hydroxide is included on this list of specific active ingredients.
安全数据
- F
- 3-9
- wgk
- -
- tsca
- TSCA listed
- 毒性
- LD50 oral in rat: 8500mg/kg
- RTECS号
- OM3570000
- 存储类别
- 13 - Non Combustible Solids
- 安全说明
- 26-36-37/39-24/25
- 海关编码
- 28161000
- 危险品标志
- Xi
- 危险类别码
- 36/37/38
- 毒害物质数据
- 1309-42-8(Hazardous Substances Data)
毒性防护
毒性ADI不作限制性规定(FAO/WHO,2001)。GRAS(FDA,§182.1428,2000)。
化学与工业
药理信息
ATC Code
G - Genito urinary system and sex hormones
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
QG - Genito urinary system and sex hormones
Pharmacodynamics
As an antacid, magnesium hydroxide suspension neutralizes gastric acid by reacting with hydrochloric acid in the stomach to form magnesium chloride and water. It is practically insoluble in water and does not have any effect until it reacts with the hydrochloric acid in the stomach. There, it decreases the direct acid irritant effect and increases the pH in the stomach leading to inactivation of pepsin. Magnesium hydroxide enhances the integrity of the mucosal barrier of the stomach as well as improving the tone of both the gastric and esophageal sphincters. As a laxative, the magnesium hydroxide works by increasing the osmotic effect in the intestinal tract and drawing water in. This creates distension of the colon which results in an increase in peristaltic movement and bowel evacuation.
Mechanism of Action
The suspension of magnesium hydroxide is ingested and enters the stomach. According to the amount ingested, the magnesium hydroxide will either act as an antacid or a laxative. Through the ingestion of 0.5-1.5 grams (in adults) the magnesium hydroxide will act by simple acid neutralization in the stomach. The hydroxide ions from the magnesium hydroxide suspension will combine with the acidic H+ ions of the hydrochloric acid made by the stomachs parietal cells. This neutralization reaction will result in the formation of magnesium chloride and water. Through the ingestion of 2-5 grams (in adults) the magnesium hydroxide acts as a laxative in the colon. The majority of the suspension is not absorbed in the intestinal tract and will create an osmotic effect to draw water into the gut from surrounding tissues. With this increase of water in the intestines, the feces will soften and the intraluminal volume of the feces will increase. These effects still stimulate intestinal motility and induce the urge to defecate. Magnesium hydroxide will also release cholecystokinin (CCK) in the intestines which will accumulate water and electrolytes in the lumen and furthermore increase intestinal motility.
COMPD IS PRACTICALLY INSOL, & SOLUTION IS NOT EFFECTED UNTIL HYDROXIDE REACTS WITH HYDROCHLORIC ACID TO FORM MAGNESIUM CHLORIDE. ...MG(OH)2 INCREASES LOWER-ESOPHAGEAL SPHINCTER PRESSURE & ACID SECRETION IN HEIDENHAIN POUCHES.
Laxatives containing magnesium cations or phosphate anions are commonly called saline laxatives. Their cathartic action is believed to result from osmotically mediated water retention, which then stimulates peristalsis. However, other mechanisms may contribute to their effects, including the production of inflammatory mediators. It also has been suggested that magnesium containing laxatives stimulate the release of cholecystolkinin, which leads to intraluminal fluid and electrolyte accumulation as well as to increased intestinal motility. /Saline laxatives, including magnesium hydroxide/
Metabolism/Metabolites
Unless a patient is deficient in magnesium, very little is absorbed by the intestine. Overall, about 15%-50% of the magnesium hydroxide suspension is absorbed systemically. However, it does not undergo any metabolism as it is rapidly excreted in the urine.
FDA Pharmacological Classification
MAGNESIUM HYDROXIDE
Osmotic Laxative [EPC]; Magnesium Ion Exchange Activity [MoA]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Increased Large Intestinal Motility [PE]; Calculi Dissolution Agent [EPC]; Osmotic Activity [MoA]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
PHILLIPS FRESH MINT MILK OF MAGNESIA
Magnesium Ion Exchange Activity [MoA]; Osmotic Laxative [EPC]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Increased Large Intestinal Motility [PE]; Calculi Dissolution Agent [EPC]; Osmotic Activity [MoA]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
PHILLIPS MILK OF MAGNESIA WILD CHERRY
Calculi Dissolution Agent [EPC]; Osmotic Activity [MoA]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Laxative [EPC]; Magnesium Ion Exchange Activity [MoA]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Increased Large Intestinal Motility [PE]
Absorption, Distribution and Excretion
About 15%-50% of magnesium hydroxide is absorbed very slowly through the small intestine.
After oral administration, up to 50% of the magnesium hydroxide suspension may be absorbed as magnesium ions through the small intestines and then rapidly excreted in the urine through the kidneys. The unabsorbed drug is mainly excreted in the feces and saliva.
The peak action and distribution of magnesium hydroxide are variable.
Magnesium hydroxide is mainly excreted in the urine by the kidneys. Since the kidneys play a major role in its clearance, individuals with renal failure are at risk of hypermagnesemia with long term consumption as the appropriate amounts of magnesium may not be excreted.
ALTHOUGH MG(OH)2 IS CLASSIFIED AS A NONSYSTEMIC ANTACID, 5 TO 10% OF MAGNESIUM CAN BE ABSORBED... ORDINARILY THE ABSORBED MAGNESIUM ION IS RAPIDLY EXCRETED BY KIDNEY. IN NORMAL PERSONS, ABSORPTION IS ATTENDED BY LITTLE OR NO DANGER OF SYSTEMIC ALKALOSIS, BUT URINE MAY BECOME ALKALINE.
...EMPTIED SLOWLY FROM THE STOMACH, PROLONGING ITS ANTACID ACTION. ...ABOUT 5-15% OF INGESTED MAGNESIUM IS ABSORBED, & THIS IS READILY EXCRETED IN THE URINE IF KIDNEY FUNCTION IS NORMAL.
用途与制造
Uses
CIR ingredient: Magnesium Hydroxide
Found naturally as brucite; [Hawley] Used to make magnesium metal and compounds (dead-burned and caustic-burned magnesia and magnesium oxide, chloride, carbonate, and sulfate), and as an antacid and laxative, a clarifier in sugar refining, and as a residual fuel oil additive; Also used for uranium processing, wastewater treatment, sulfur dioxide removal from waste gases, and neutralization of acids in the chemical industry; Also used in toothpastes and dentrifrices, in foods as a drying and color-retention agent, in frozen desserts, in the pulp and paper industries, and in other products (ceramics, pharmaceuticals, plastics, and flame retardants/smoke suppressants); [HSDB] Used as an alkali and color adjunct; [JECFA]
Metal Preparation and Pouring [Category: Foundry]
Ceramics making [Category: Hobbies]
CHEM INT FOR DEAD-BURNED & CAUSTIC-BURNED MAGNESIA, MAGNESIUM CHLORIDE & MAGNESIUM CARBONATE; RAW MATERIAL FOR MAGNESIUM METAL; INGREDIENT IN TOOTHPASTE; NEUTRALIZATION OF ACIDS IN THE CHEMICAL INDUSTRY; ... CLARIFIER IN SUGAR REFINING
RESIDUAL FUEL OIL ADDITIVE; SULFITE PULP; URANIUM PROCESSING; DENTRIFRICES; IN FOODS AS DRYING AGENT, COLOR RETENTION AGENT; FROZEN DESSERTS
U.S. Production
2023: 400,000,000 - <550,000,000 lb
(1974) 8.46X10+10 GRAMS (USE)
Methods of Manufacturing
REACTION OF CALCIUM HYDROXIDE WITH SEA WATER WHICH HAS BEEN PURIFIED TO REMOVE COLLOIDAL PARTICLES, CARBON DIOXIDE, AND SALTS OF OTHER METALS
...FROM MAGNESIUM CHLORIDE OR SULFATE & SODIUM HYDROXIDE...US 3127241 (1964 TO DOW). INDUSTRIAL METHOD FOR PRODUCING MAGNESIUM HYDROXIDE HAVING VARIABLE PARTICLE SIZES...US 3232708 (1966 TO FMC).
Precipitation from a solution of a magnesium salt by sodium hydroxide or precipitation from seawater with lime.
Dead Sea Periclase (DSP, Mishor Rotem, Israel) converts magnesium chloride into MgO by spray-roasting, then hydrates the MgO to Mg(OH)2.
Magnesite is acidified to produce MgCl2 and subsequent MgO of 99% purity, which is converted to magnesium hydroxide by hydration.
Formulations/Preparations
MILK OF MAGNESIA USP, IS AN AQUEOUS SUSPENSION OF MAGNESIUM HYDROXIDE CONTAINING 7.0-8.5% OF MG(OH)2. EACH MILLILITER IS CAPABLE OF NEUTRALIZING APPROX 2.7 MEQ OF ACID. ...MAGNESIUM HYDROXIDE IS ALSO AVAIL AS MAGNESIA TABLETS...GENERALLY CONTAIN 325 MG EACH, WHICH CAN NEUTRALIZE 11.2 MEQ OF ACID.
USP; 250 ML & 500 ML BOTTLES WITH ALUMINUM HYDROXIDE GEL; 250 ML, 375 ML, 500 ML & 1 L BOTTLES.
SUSPENSION OF 30% MAGNESIUM HYDROXIDE IN WATER: HYDRO-MAGMA.
MAGNESIUM HYDROXIDE DRUG AVAILABLE GENERICALLY: POWDER; TABLETS 300 & 600 MG.
For more Formulations/Preparations (Complete) data for MAGNESIUM HYDROXIDE (9 total), please visit the HSDB record page.
Use Classification
EPA Safer Chemical Functional Use Classes -> Processing Aids and Additives
Safer Chemical Classes -> Green circle - The chemical has been verified to be of low concern
Food additives
Food Additives -> ACIDITY_REGULATOR; COLOUR_RETENTION_AGENT -> JECFA Functional Classes
Cosmetics -> Buffering; Absorbent
Plastics -> Polymer Type -> Polyolefin-I; Polyolefin-II; ABS
General Manufacturing Information
Mining (except Oil and Gas) and support activities
Magnesium hydroxide (Mg(OH)2): ACTIVE
INCOMPATIBILITIES: ...HAS AN ALKALINE REACTION & POSSESSES INCOMPATIBILITIES TYPICAL OF SUCH REACTION. THUS, ALKALOIDS ARE LIBERATED FROM SOLN OF THEIR SALTS. /MILK OF MAGNESIA USP/
...HIGH NEUTRALIZING CAPACITY WITH RAPID ONSET... AS WITH ALL AMPHOTERIC ANTACIDS, TABLETS ARE LESS EFFECTIVE THAN LIQUID PREPARATIONS.
MAGNESIUM HYDROXIDE IS DISPERSED IN WATER CONTAINING SODIUM POLYMETHACRYLATE TO PRODUCE A HIGHLY CONCENTRATED MAGNESIUM HYDROXIDE SLURRY OF LOW VISCOSITY FOR WASTE GAS DESULFURIZATION.
Unlike other magnesium hydroxide products, the Mg(OH)2 in milk of magnesia is produced from basic magnesium carbonate. The fine particle structure formed in this reaction makes milk of magnesia a stable slurry.
应用领域
用途用作分析试剂,也用于制药工业,在医药上用作抗酸剂和缓泻剂,还可用于制糖和氧化镁等。
用途氢氧化镁是一种高填充量与添加型的无机阻燃剂与抑烟剂。受热时,发生分解吸收燃烧物表面热量达到阻燃作用;同时,释放出大量地水分稀释燃物表面的氧气,而分解生成的活性氧化镁会附着在可燃物的表面,进一步阻止燃烧的进行。在整个阻燃过程中,氢氧化镁并没有产生任何有害物质,而且分解出的产物在阻燃的同时,还可以大量地吸收塑料、橡胶等高分子燃烧生成的有害气体与烟雾,是一种新兴的的环保型无机阻燃剂。
制备方法
生产方法卤水一石灰法将预先经过净化精制处理的卤水和经消化除渣处理的石灰制成的石灰乳在沉淀槽内进行沉淀反应,在得到的料浆中加入絮凝剂,充分混合后,进入沉降槽进行分离,再经过滤、洗涤、烘干、粉碎,制得氢氧化镁成品。其MgCl2+Ca(OH)2→CaCl2+Mg(OH)2.卤水-氨水法以经净化处理除去硫酸盐、二氧化碳、少量硼等杂质的卤水为原料,以氨水作为沉淀剂在反应釜中进行沉淀反应,在反应前投入一定量的晶种,进行充分搅拌。卤水与氨水的比例为1:(0.9~0.93),温度控制在40℃。反应终了后添加絮凝剂,沉淀物经过滤后,洗涤、烘干、粉碎,制得氢氧化镁成品。其MgC12+2NH3·H2O→Mg(OH)2+2NH4Cl该试验方法有待提高收率,缩短洗涤周期,改进并完善生产工艺。菱苦土-盐酸-氨水法菱镁矿石与无烟煤或焦炭在竖窑内煅烧,生成氧化镁和二氧化碳。苦土粉用水调成浆状后与规定浓度的盐酸反应制备氯化镁溶液。其氯化镁溶液与一定浓度的氨水在反应器中进行反应,生成物经洗涤、沉降、过滤分离、干燥、粉碎,得到氢氧化镁产品。根据需要可添加表面处理剂进行表面处理。
上下游产品信息
上游原料
下游产品
试剂价格
- 012367 · 100g
- 氢氧化镁, 95-100.5%Magnesium hydroxide, 95-100.5% — 199元
- 31572 · 25g
- 氢氧化镁, 95-100.5%Magnesium hydroxide, 95%, pure, Thermo Scientific Chemicals — 245元
供应商50 家
相关反应
关联笔记
加载中…